Shanghai Junshi Biosciences Co., Ltd. (1877.HK)

17.480 -1.120 (-6.02%) At close: 04:08PM HKT

Shanghai Junshi Biosciences Co., Ltd.

Building 7
15th Floor No.6, Lane 100, Pingjiaqiao Road Pudong New Area
Shanghai 200126
China
86 21 6105 8800
https://www.junshipharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2,772

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jun Xiong	Exec. Chairman	N/A	N/A	1974
Dr. Ning Li	Co-CEO, GM & Exec. Director	N/A	N/A	1962
Mr. Cong Li	Co-CEO & Exec. Director	N/A	N/A	1964
Mr. Baohong Xu	Financial Director	N/A	N/A	1979
Mr. Zhuobing Zhang	Deputy GM & Exec. Director	N/A	N/A	1968
Dr. Sheng Yao	Sr. VP & Exec. Director	N/A	N/A	1976
Mr. Gang Wang	Chief Quality Officer & Sr. VP of Industry Affairs	N/A	N/A	1957
Dr. Jianjun Zou	Deputy GM, Global R&D Pres and Exec. Director	N/A	N/A	1972
Ms. Yingge Chen	Joint Company Sec.	N/A	N/A	1992
Ms. Lu Yuan	Assistant to GM & Chief of Internal Audit Department	N/A	N/A	1982

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

Corporate governance

Shanghai Junshi Biosciences Co., Ltd.’s ISS governance QualityScore as of 28 September 2023 is 6. The pillar scores are Audit: 6; Board: 6; Shareholder rights: 9; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.